Anthony DiGiandomenico
Direttore/Membro del Consiglio presso ENDRA LIFE SCIENCES INC.
Patrimonio netto: 11 M $ in data 31/05/2024
Posizioni attive di Anthony DiGiandomenico
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ENDRA LIFE SCIENCES INC. | Direttore/Membro del Consiglio | 01/07/2013 | - |
| Independent Dir/Board Member | 01/07/2013 | - | |
| MDB CAPITAL HOLDINGS, LLC | Direttore/Membro del Consiglio | 10/08/2021 | - |
| Corporate Officer/Principal | 10/08/2021 | - | |
Pier Acquisition I, Inc.
 Pier Acquisition I, Inc. Financial ConglomeratesFinance Pier Acquisition I, Inc. operates as a blank check company. The company was founded on August 14, 2008 and is headquartered in Calabasas, CA. | Direttore/Membro del Consiglio | 16/11/2009 | - |
Pier Acquisition II, Inc.
 Pier Acquisition II, Inc. Financial ConglomeratesFinance Pier Acquisition II, Inc. was incorporated in the State of Delaware on August 14, 2008. Since inception, the Company has been engaged in organizational efforts and obtaining initial financing. The Company was formed as a vehicle to pursue a business combination and has made no efforts to identify a possible business combination. The Company is considered to be a 'blank check' company. The U.S. Securities and Exchange Commission (the 'SEC') defines as a development stage company. | Direttore/Membro del Consiglio | 16/11/2009 | - |
National Association of Securities Dealers, Inc.
 National Association of Securities Dealers, Inc. Investment Banks/BrokersFinance National Association of Securities Dealers, Inc. provides financial regulatory services. The non-profit company is based in Washington and has subsidiaries in the United States. The American company was founded by Richard B. Jennings, Vince Means. | Corporate Officer/Principal | 25/07/2011 | - |
Invizyne Technologies, Inc.
 Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV. | Direttore/Membro del Consiglio | 01/04/2019 | - |
Storia della carriera di Anthony DiGiandomenico
Precedenti posizioni note di Anthony DiGiandomenico
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PROVENTION BIO, INC. | Direttore/Membro del Consiglio | 01/04/2017 | 19/05/2020 |
| Independent Dir/Board Member | 01/04/2017 | 19/05/2020 | |
| CUE BIOPHARMA, INC. | Direttore/Membro del Consiglio | 01/06/2015 | 03/10/2019 |
| CHARLIE'S HOLDINGS, INC. | Direttore/Membro del Consiglio | 25/05/2004 | 15/10/2012 |
| ░░░░░ ░░░░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░░ | - | - |
Formazione di Anthony DiGiandomenico
| The University of Colorado | Undergraduate Degree |
| Haas School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 13 |
| Giappone | 2 |
| 2 |
Posizioni
| Director/Board Member | 9 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 2 |
Settori
| Finance | 6 |
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| CHARLIE'S HOLDINGS, INC. | Producer Manufacturing |
| ENDRA LIFE SCIENCES INC. | Health Technology |
| CUE BIOPHARMA, INC. | Health Technology |
| Aziende private | 9 |
|---|---|
| Orion Acquisition Corp. II | Finance |
Public Ventures LLC
 Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Finance |
Pier Acquisition I, Inc.
Pier Acquisition I, Inc. Financial ConglomeratesFinance Pier Acquisition I, Inc. operates as a blank check company. The company was founded on August 14, 2008 and is headquartered in Calabasas, CA. | Finance |
Pier Acquisition II, Inc.
Pier Acquisition II, Inc. Financial ConglomeratesFinance Pier Acquisition II, Inc. was incorporated in the State of Delaware on August 14, 2008. Since inception, the Company has been engaged in organizational efforts and obtaining initial financing. The Company was formed as a vehicle to pursue a business combination and has made no efforts to identify a possible business combination. The Company is considered to be a 'blank check' company. The U.S. Securities and Exchange Commission (the 'SEC') defines as a development stage company. | Finance |
National Association of Securities Dealers, Inc.
National Association of Securities Dealers, Inc. Investment Banks/BrokersFinance National Association of Securities Dealers, Inc. provides financial regulatory services. The non-profit company is based in Washington and has subsidiaries in the United States. The American company was founded by Richard B. Jennings, Vince Means. | Finance |
| Digian Co. | |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
| MDB Capital Holdings LLC | |
Invizyne Technologies, Inc.
Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV. | Process Industries |
